Company profile

Facts and figures

Development and innovation, brands and an international presence: the key facts and figures for URSAPHARM Arzneimittel GmbH at a glance.

  • Founding of URSAPHARM Arzneimittel GmbH in 1974
  • Headquarters and production site: Saarbrücken
  • Main activities: manufacture of pharmaceuticals and medical products for general practice as well as ophthalmology and rhinology
  • Dosage forms produced: eye drops, eye ointment, nasal sprays, nasal drops, nasal ointment, granules, tablets, film-coated tablets and capsules
  •  Management:
    • Frank Holzer
    • Dominik Holzer
  • Group annual turnover 2021: 284 million euros
  • Most important brands: HYLO®, hysan®, aronia+, Bromelain-POS®, Zinkorotat-POS®, POSIFORLID®
  • Over 950 highly qualified employees in Saarbrücken and the distribution locations
  • Sales offices in France, Benelux, Austria, Switzerland, Italy, Poland, the Czech Republic, Slovakia, Serbia, Portugal, Russia and India
  • Partnership agreements with distribution partners in over 80 countries
  • Launch of the patented COMOD® system in 1993. The system makes it possible to keep liquid contents sterile and free of pathogens for a period of at least 6 months without the addition of preservatives.
  • Quality standards:
    • DIN EN ISO 9001:2015
    • DIN EN ISO 13485:2016
    • EU GMP/cGMP standard

We use a cookie-less web analysis tool (etracker). For more information and to opt-out, please click here.